🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

William Blum

Emory University

ORCID: 0000-0003-0111-7465

Also affiliated with Cancer Institute (WIA)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801”.

Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801

Blood Advances(2020)10.1182/bloodadvances.2019000492

N/A

2.8DataRank · unranked

72 citations

Susan M. Geyer, Kristina Laumann, Weiqiang Zhao, Donna Bucci, Geoffrey L. Uy +12 more

Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)

Leukemia(2023)10.1038/s41375-023-02068-8

N/A

1.8DataRank · unranked

39 citations

Deedra Nicolet, Krzysztof Mrózek, Ayse S. Yilmaz, Jessica Kohlschmidt, Karilyn Larkin +35 more

Lysine acetylation restricts mutant IDH2 activity to optimize transformation in AML cells

Molecular Cell(2021)10.1016/j.molcel.2021.06.027

N/A

1.0DataRank · unranked

24 citations

Siyuan Xia, Rukang Zhang, Yuancheng Li, Christopher Famulare, Hao Fan +20 more

Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)

Blood Advances(2021)10.1182/bloodadvances.2021004233

N/A

1.0DataRank · unranked

30 citations

Guido Marcucci, Jun Yin, William Blum, Wendy Stock, Jessica Kohlschmidt +15 more

Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates

Blood Advances(2022)10.1182/bloodadvances.2022008625

N/A

0.839DataRank · unranked

19 citations

Scott H. Kaufmann, Eytan M. Stein, Prapti A. Patel, Maria R. Baer, Wendy Stock +35 more

Association of social deprivation with survival in younger adult patients with AML: an Alliance study

Blood Advances(2023)10.1182/bloodadvances.2022009325

N/A

0.524DataRank · unranked

9 citations

Jessica Kohlschmidt, Krzysztof Mrózek, Deedra Nicolet, Alice S. Mims, James S. Blachly +15 more

Streamlined Operational Approaches and Use of e-Technologies in Clinical Trials: Beat Acute Myeloid Leukemia Master Trial

Therapeutic Innovation & Regulatory Science(2021)10.1007/s43441-021-00277-w

N/A

0.353DataRank · unranked

5 citations

Hugh Levaux, Ross L. Levine, Amit Shah, James Denmark, Nyla Hereema +18 more

A phase 1 study of IO-202, an anti-LILRB4 antibody, in chronic myelomonocytic leukemia and acute myeloid leukemia

Blood Neoplasia(2025)10.1016/j.bneo.2025.100126

N/A

0.330DataRank · unranked

8 citations

Gabriel N. Mannis, Yazan F. Madanat, Brian A. Jonas, Neil Dunavin, Gail J. Roboz +15 more

Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology)

Leukemia(2025)10.1038/s41375-025-02644-0

N/A

0.165DataRank · unranked

2 citations

Karilyn Larkin, Deedra Nicolet, Vindi Jurinović, Krzysztof Mrózek, Aarif M.N. Batcha +30 more

Cytarabine Pharmacogenomics and Outcomes Among Children and Young Adults With Acute Myeloid Leukemia

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.16296

N/A

0.104DataRank · unranked

1 citations

Vivek M. Shastri, Deedra Nicolet, Krzysztof Mrózek, Christopher J. Walker, William Blum +19 more

Olutasidenib for the Treatment of mIDH1 Acute Myeloid Leukemia in Patients Relapsed or Refractory to Hematopoietic Stem Cell Transplant, Prior mIDH1 Inhibitor, or Venetoclax

Blood(2023)10.1182/blood-2023-187861

N/A

0DataRank · unranked

5 citations

Joseph G. Jurcic, Maria R. Baer, William Blum, P. Brent Ferrell, Brian A. Jonas +7 more

Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study

Leukemia(2023)10.1038/s41375-023-01846-8

N/A

0DataRank · unranked

74 citations

Jessica Kohlschmidt, James S. Blachly, Deedra Nicolet, Andrew J. Carroll, Kellie J. Archer +14 more

High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML

Blood Advances(2022)10.1182/bloodadvances.2022007544

N/A

0DataRank · unranked

35 citations

Deedra Nicolet, Benjamin Kelly, Krzysztof Mrózek, Stephanie LaHaye, Katherine E. Miller +25 more

Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studies

Leukemia(2025)10.1038/s41375-024-02498-y

N/A

0DataRank · unranked

4 citations

Deedra Nicolet, Najla Alotaibi, Daelynn R. Buelow, Shelley Orwick, Charles T. Gregory +15 more

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502

UNC Libraries(2020)10.17615/d8vv-vc17

N/A

0DataRank · unranked

0 citations

William Blum, Flora Mulkey, Richard M. Stone, Shelly Carter, Charles Linker +15 more